Moo H. Kim
Experienced in AIDS Dementia Complex

Moo H. Kim

Busan, KR 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in AIDS Dementia Complex
Busan, KR 
OverviewLocationsClinical Research

Overview

Moo Kim practices in Busan, Republic of Korea. Mr. Kim is rated as an Experienced expert by MediFind in the treatment of AIDS Dementia Complex. His top areas of expertise are Coronary Heart Disease, Heart Attack, Coronary Artery Spasm, Percutaneous Coronary Intervention (PCI), and Angioplasty.

His clinical research consists of co-authoring 218 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of AIDS Dementia Complex.

Gender
Male

Locations

Busan, Republic of Korea
Other Locations
Republic of Korea
Seoul, Republic of Korea
Wondu, Republic of Korea
Daegu, Republic of Korea
Ulsan, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

EASTYLE (DE-escAlation Strategy for Optimal Ticagrelor Therapy in Acute MYocardiaL Infarction PatiEnts, Prospective, Multicenter, Randomized) Trial
EASTYLE (DE-escAlation Strategy for Optimal Ticagrelor Therapy in Acute MYocardiaL Infarction PatiEnts, Prospective, Multicenter, Randomized) Trial
Enrollment Status: Recruiting
Publish Date: October 01, 2025
Intervention Type: Drug
Study Drug: Ticagrelor
Study Phase: Phase 4
Phase 3 Study Comparing the Efficacy and Safety of Prasugrel and Clopidogrel in Acute Coronary Syndrome Patients With CYP2C19 Polymorphism Who Undergo Percutaneous Coronary Intervention.
Phase 3 Study Comparing the Efficacy and Safety of Prasugrel and Clopidogrel in Acute Coronary Syndrome Patients With CYP2C19 Polymorphism Who Undergo Percutaneous Coronary Intervention.
Enrollment Status: Completed
Publish Date: February 11, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

218 Total Publications

Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES Registry.
Long-Term Impact of Platelet Reactivity and Clinical Risk on Clinical Outcomes in Patients With Coronary Artery Disease: Analysis of the PTRG-DES Registry.
Journal: Circulation. Cardiovascular interventions
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kim's expertise for a condition
ConditionClose
    View All 21 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile